Cat. No.: DIA-0243096
Product Information | |
---|---|
CAS No. | 1187061-62-6 |
Formula | C51H44Cl2N4O6 |
Molecular Weight | 879.82 |
SMILES | O=C(O)[C@@H](NC([C@@H]1CC2=C(CN1[C@H](C3=CC=CC=C3)CC)C=C(O[C@H](C4=CC=C(OCC5=CC=C(Cl)C(Cl)=C5)C=C4)C(N6C)=O)C6=C2)=O)CC7=CC=C(C8=CC=C(C#N)C=C8)C=C7 |
Target | GCGR |
Product Description | GLP-1 receptor agonist 4 is a glucagon-like peptide-1 receptor (GLP-1R) agonist extracted from patent WO2009111700A2, compound 87, has an EC50 of 64.5 nM. GLP-1 receptor agonist 4 can be used in the research for treatment of diabetes. |
Format & Storage | |
---|---|
Shipping | Room temperature in the continental U.S. Other areas may vary. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.